Searched for
SYMBIOTEC PHARMALAB STOCK PRICE
Symbiotec Pharmalab shares to list today; GMP signals 19% listing gainThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...- US Stocks Today: US stocks fall as Iran war escalation sends oil prices upUS stock indexes declined as oil prices rose due to escalating US-Iran conflict. Inflation concerns grew after Fed Chair Kevin Warsh's hawk...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 24%US bond yields remain elevated, suggesting that the debt market expects inflation to move up. Now, if the risk-free returns indicated by th...
- IPO rush continues: 7 issues to raise over Rs 1,400 crore this weekThis week, investors can look forward to three mainboard initials and four SME IPOs, with a combined goal of raising over ₹1,400 crore in t...
- IPO fever grips D-Street: 3 issues to open for subscription; 8 new listings lined up for next weekIndia’s primary market is set for a busy week, with three mainboard IPOs opening to raise a combined Rs 1,264.72 crore. Meanwhile, eight co...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 31%When the Indian market will start to recover in any real sense is still an open question. But one positive is that the broader market indic...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Lalithaa Jewellery Mart shares shine on debut, list at 32% premium over IPO priceLalithaa Jewellery Mart Share Price: Lalithaa Jewellery Mart made a remarkable entrance on Monday, entering the stock market with a strong ...
- Rs 21,000 crore IPO rush in August highest in one year. Will September break all records?In August, India's IPO market witnessed a remarkable recovery, becoming the most active month in nearly a year. Over twenty companies succe...
- IPO rush continues: 10 issues to raise over Rs 3,500 crore this weekThis week sees the launch of six mainboard IPOs and four from the SME sector, with total fundraising expected to surpass Rs 3,500 crore. Am...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- 20 IPOs on investors' radar next week. GMPs indicate up to 90% returnsA total of 20 IPOs are on investors’ radar next week, including fresh issues and upcoming listings across the mainboard and SME segments. S...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth ...
- Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 croreAarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year rise in Q1 FY27 net profit to Rs 76.14 cr...
Load More
